SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Borowitz MJ,Craig FE,DiGiuseppe JA,Illingworth AJ,Rosse W,Sutherland DR,Wittwer CT,Richards SJ; On Behalf of the International Clinical Cytometry Society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B: Clin Cytom 2010; 78B: 211230.
  • 2
    Battiwalla M,Hepgur M,Pan D,McCarthy PL,Ahluwalia MS,Camacho SH,Starostik P,Wallace PK. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations. Cytometry B: Clin Cytom 2010; 78B: 348356.
  • 3
    Larsen HO,Roug AS,Just T,Brown GD,Hokland P. Expression of the hMICL in acute myeloid leukemia—a highly reliable disease marker at diagnosis and during follow-up. Cytometry B: Clin Cytom 2012; 82B: 38.
  • 4
    Matarraz S,López A,Barrena S,Fernandez C,Jensen E,Flores-Montero J,Rasillo A,Sayagues JM,Sánchez ML,Bárcena P,Hernandez-Rivas JM,Salvador C,Fernandez-Mosteirín N,Giralt M,Perdiguer L,Laranjeira P,Paiva A,Orfao A. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients. Cytometry B: Clin Cytom 2010; 78B: 154168.
  • 5
    Finn WG,Harrington AM,Carter KM,Raich R,Kroft SH,Hero AO 3rd. Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling. Cytometry B: Clin Cytom 2011; 80B: 282290.
  • 6
    la Porta MG,Lanza F,Del Vecchio L. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. Cytometry B: Clin Cytom 2011; 80B: 201211.
  • 7
    Vasconcelos FC,Silva KL,de Souza PS,Silva LFR,Moellmann-Coelho A,Klumb CE,Maia RC. Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients. Cytometry B: Clin Cytom 2011; 80B: 158166.
  • 8
    Sattui S,de la Flor C,Sanchez C,Lewis D,Lopez G,Rizo-Patrón E,White AC Jr,Montes M. Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B: Clin Cytom 2012; 82B: 5458.
  • 9
    Abayomi EA,Landis RC. Flow cytometry as the spearhead for delivering sustainable and versatile laboratory services to HIV-burdened health care systems of the developing world: a Caribbean model. Cytometry B: Clin Cytom 2008; 74B ( Suppl 1): S80S89.
  • 10
    Hansen P,Barry D,Restell A,Sylvia D,Magnin O,Dombkowski D,Preffer F. Physics of a rapid CD4 lymphocyte count with colloidal gold. Cytometry A 2012; 81A: 222231.
  • 11
    Janossy G,Mandy F. Translational medicine as implementation science in the field of monitoring HIV and TB. New concepts emanating from resource-poor countries. Cytometry B: Clin Cytom 2010; 78B: 183187.
  • 12
    Lawrie D,Coetzee LM,Glencross DK. A model for continuous quality control incorporating sample-to-sample assessment of optical alignment, fluorescence sensitivity, and volumetric operation of flow cytometers. Cytometry B: Clin Cytom 2010; 78B: 201210.